Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1831154863
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
100 Hospital Ln, Suite 205
Indianapolis, IN, 46202
Phone (317) 745-7445
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
15,362 services
Medicare patients, 2024
385
Average age 73
Drug cost, 2024
$1.9M
4,889 prescriptions
Company payments, 2025
$2,152
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James W Edmondson was code J1306 (injection, inclisiran, 1 mg), 7,668 times for 15 patients. In total James W Edmondson billed 15,362 services in 17 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 7,668 | 15 | $9.52 | $73K |
| J0897 Injection, denosumab, 1 mg | Office | 3,600 | 38 | $20.38 | $73K |
| 99214 Office E&M - Established | Office | 493 | 293 | $89.23 | $44K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 343 | 264 | $12.40 | $4,255 |
| 83036 Blood Count | Office | 279 | 148 | $9.49 | $2,647 |
| 96372 Injection Administration | Office | 116 | 58 | $10.92 | $1,267 |
| 99213 Office E&M - Established | Office | 64 | 64 | $62.85 | $4,022 |
| 99204 Office E&M - New | Office | 46 | 46 | $109.10 | $5,019 |
By year: 2022 $91K for 4,225 services; 2023 $145K for 7,062 services; 2024 $232K for 15,362 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 279 | 148 | $9.49 | $2,647 |
Medicare prescription drug claims, 2024
In 2024, the drug James W Edmondson prescribed most often to Medicare patients was Ozempic (Semaglutide), with 505 prescriptions and refills. In total James W Edmondson wrote 4,889 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 505 | 625 | 87 | $570K |
| Levothyroxine Sodium Generic | 332 | 933 | 100 | $2,964 |
| Rosuvastatin Calcium Generic | 229 | 604 | 69 | $2,574 |
| Atorvastatin Calcium Generic | 220 | 615 | 70 | $2,369 |
| Mounjaro Tirzepatide | 194 | 213 | 24 | $223K |
| Glimepiride Generic | 183 | 475 | 54 | $1,317 |
| Pioglitazone Hcl Generic | 161 | 449 | 50 | $2,079 |
| Synthroid Levothyroxine Sodium | 155 | 433 | 45 | $19K |
| Metformin Hcl Generic | 142 | 398 | 41 | $1,232 |
| Methimazole Generic | 129 | 320 | 39 | $1,195 |
| Metformin Hcl Er Metformin Hcl | 118 | 344 | 39 | $1,114 |
| Trulicity Dulaglutide | 114 | 150 | 21 | $145K |
| Jardiance Empagliflozin | 109 | 201 | 24 | $119K |
| Glipizide Er Glipizide | 98 | 294 | 31 | $2,493 |
| Spironolactone Generic | 93 | 232 | 33 | $809 |
Brand drugs: 2,201 claims; generic drugs: 2,449 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James W Edmondson $2,152 ($2,152 in general payments such as food, travel and fees) from 26 companies. The largest payer was Amgen Inc. with $345.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 31 | $345 |
| Novo Nordisk Inc NVO | 23 | $316 |
| Lilly USA, LLC LLY | 14 | $229 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $166 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $165 |
| Amneal Pharmaceuticals LLC AMRX | 9 | $156 |
| Xeris Pharmaceuticals, Inc. | 6 | $95.34 |
| Abbott Laboratories ABT | 5 | $87.65 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $56.17 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $50.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.